IL20RB as a prognostic and immune-related biomarker in lung cancer: association with immune infiltration, tumor progression, and potential therapeutic targeting

Key Points

• IL20RB expression serves as an independent prognostic factor for lung cancer outcomes, indicating its potential clinical utility.
• Increased immune infiltration in tumors correlates with higher IL20RB expression, highlighting its role in immune response.
• Assessment through patient data demonstrates IL20RB's relevance in guiding immunotherapy strategies for lung cancer treatment.
• Potential therapeutic targeting of IL20RB may enhance cancer treatments, emphasizing the need for further exploration in clinical settings.